@dansfera: The biggest misconception about FDA waivers, exposed! A cleared clinical safety profile is a win, but it absolutely *does not* guarantee final drug approval. Watch closely as the speaker unpacks how technical pitfalls—from tricky manufacturing processes to unexpected pharmacokinetics—can still land a sponsor with a dreaded Complete Response Letter, even after the FDA skips the advisory committee review. The regulatory landscape is far more nuanced than just getting that waiver checkmark. Next major point: the eternal debate of Novelty versus Precedent. \#FDARegulation \#Pharma \#DrugDevelopment \#Biotech \#RegulatoryAffairs

dansfera

Open In TikTok:

Region: US

Friday 09 January 2026 21:41:29 GMT